Skip to main content
OpenTrials

Clinical trial condition

Leukemia

Explore clinical trials studying Leukemia. Study availability and eligibility vary by location and protocol.

4,415 public trials 1,033 recruiting studies
Refine in advanced search Browse all conditions

Leukemia trial results

Completed

Dosing Study of Ara-C/EL625/Idarubicin in Refractory and Relapsed AML

NCT00074737

Conditions
Acute Myelogenous Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations
  • University of California, San Diego La Jolla, California, United States
  • University of Miami Health Center Miami, Florida, United States
  • Washington University Medical Center (Siteman Cancer Center) St Louis, Missouri, United States
  • Roswell Park Cancer Institute Buffalo, New York, United States
View Trial Details
Completed

Bortezomib, Daunorubicin, and Cytarabine in Treating Older Patients With Previously Untreated Acute Myeloid Leukemia

NCT00742625

Conditions
Acute Myeloid Leukemia, Adult Acute Megakaryoblastic Leukemia (M7), Adult Acute Minimally Differentiated Myeloid Leukemia (M0), +27 more
Locations
  • Washington Hospital Center Washington D.C., District of Columbia, United States
  • Lombardi Comprehensive Cancer Center at Georgetown University Washington D.C., District of Columbia, United States
  • Florida Hospital Orlando, Florida, United States
  • University of Chicago Chicago, Illinois, United States
View all 22 locations
View Trial Details
Completed

Vorinostat and Decitabine in Treating Patients With Advanced Solid Tumors or Relapsed or Refractory Non-Hodgkin's Lymphoma, Acute Myeloid Leukemia, Acute Lymphocytic Leukemia, or Chronic Myelogenous Leukemia

NCT00275080

Conditions
Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Inv(16)(p13;q22), Adult Acute Myeloid Leukemia With t(15;17)(q22;q12), +91 more
Locations
  • Chedoke-McMaster Hospitals Hamilton, Ontario, Canada
  • Juravinski Cancer Centre at Hamilton Health Sciences Hamilton, Ontario, Canada
  • Princess Margaret Hospital Phase 2 Consortium Toronto, Ontario, Canada
  • University Health Network-Princess Margaret Hospital Toronto, Ontario, Canada
View Trial Details

Related conditions